Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;82(3):225-6.
doi: 10.1136/sti.2005.018168.

No way back for quinolones in the treatment of gonorrhoea

P C Goold  1 , C J Bignell
Affiliations

No way back for quinolones in the treatment of gonorrhoea

P C Goold et al. Sex Transm Infect. 2006 Jun.

Abstract

Objectives: To assess the changing prevalence of quinolone resistant Neisseria gonorrhoeae (QRNG) over 3 years following implementation of cephalosporin treatment (for gonorrhoea).

Methods: Case review of all episodes of gonorrhoea diagnosed in the genitourinary medicine clinic in Nottingham during the first 6 months of each year between 2002 and 2005.

Results: The prevalence of QRNG peaked at 52.5% in January 2002. Three years after third generation cephalosporins were implemented for the treatment of gonorrhoea, QRNG persists in the local population with a prevalence of 9.1% over the first half of 2005.

Conclusions: The persistence of QRNG at a prevalence exceeding 5% precludes a return to quinolones for the treatment of gonorrhoea. The significant reduction in all cases of gonorrhoea identified over the same time is unlikely to be related to the change to treatment with cephalosporins.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none.

References

    1. Ross J D, Maw R. Bacterial Special Interest Group, and the British Clinical Co‐operative Group of the MSSVD. How is gonorrhoea treated in genitourinary medicine clinics in the UK? Int J STD AIDS 200213499–500. - PubMed
    1. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society of the Study of Venereal Diseases). National guideline for the management of gonorrhoea in adults. Sex Transm Infect 199975(Suppl 1)S13–S15. - PubMed
    1. Fenton K A, Ison C A, Johnson A P.et al Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet 20033611867–1869. - PubMed
    1. Clinical Effectiveness Group, BASHH (British Association for Sexual Health and HIV). National Guidelines for the diagnosis and treatment of gonorrhoea in adults 2005. [cited 22 September 2005] Accessible at http://www.bashh.org/guidelines/2005/gc_final_0805pdf
    1. BSAC Disc diffusion method for antimicrobial susceptibility testing. Version 4 January 2005. [Cited 12 November 2005] Available at http://www.bsac.org.uk/_db/_documents/version_4_january_2005_final_NH_ap...